GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » Gross-Profit-to-Asset %

Electromedical Technologies (Electromedical Technologies) Gross-Profit-to-Asset % : 135.42% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Electromedical Technologies's annualized Gross Profit for the quarter that ended in Dec. 2023 was $1.08 Mil. Electromedical Technologies's average Total Assets over the quarter that ended in Dec. 2023 was $0.80 Mil. Therefore, Electromedical Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 135.42%.


Electromedical Technologies Gross-Profit-to-Asset % Historical Data

The historical data trend for Electromedical Technologies's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies Gross-Profit-to-Asset % Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
65.45 46.90 50.23 64.54 99.57

Electromedical Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.59 79.62 71.30 106.53 135.42

Competitive Comparison of Electromedical Technologies's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Electromedical Technologies's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromedical Technologies's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's Gross-Profit-to-Asset % falls into.



Electromedical Technologies Gross-Profit-to-Asset % Calculation

Electromedical Technologies's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1.046/( (1.353+0.748)/ 2 )
=1.046/1.0505
=99.57 %

Electromedical Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1.084/( (0.853+0.748)/ 2 )
=1.084/0.8005
=135.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Electromedical Technologies Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Electromedical Technologies (Electromedical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260
Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.
Executives
Hymers Iii R. Leslie director 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson director PO BOX 41828, MESA AZ 41828
Donald J Steinberg 10 percent owner 3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson director, officer: CEO, CFO 16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260

Electromedical Technologies (Electromedical Technologies) Headlines